About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
On May 31, PhRMA held a media briefing at this year’s ASCO event, where PhRMA’s President and Chief Executive Officer, Steve Ubl, spoke with Robert M. Davis, Chief Executive Officer and President, Merck & Co. Inc., Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences, Inc. and David Ricks, Chair and Chief Executive Officer, Eli Lilly and Company. During the session, panelists discussed the importance of federal policies that protect the future of groundbreaking oncology discoveries.
When:
May 31, 2024, at 12:10 PM ET
Speakers:
- Robert M. Davis, Chief Executive Officer and President, Merck & Co. Inc.
- Daniel O'Day, Chairman and Chief Executive Officer, Gilead Sciences, Inc.
- David Ricks, Chair and Chief Executive Officer, Eli Lilly and Company
- Steve Ubl, President and Chief Executive Officer, PhRMA
Event
Cancer
ASCO Media Briefing
ASCO Media Briefing image